ADA Scientific Sessions 2025 Abstract

Symphony 1—A Randomized, Placebo-Controlled Phase 3 Study of Berberine Ursodeoxycholate as Monotherapy in Patients with Type 2 Diabetes

By Linong Ji, Jianhua Ma, Zhifeng Cheng, Liping Liu

Trial in peopleInterventions

The paper

Linong Ji, Jianhua Ma, Zhifeng Cheng, Liping Liu

Beijing

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, late-breaking 2001-LB

doi.org/10.2337/db25-2001-lb

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity